FI853255L - Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin. - Google Patents

Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.

Info

Publication number
FI853255L
FI853255L FI853255A FI853255A FI853255L FI 853255 L FI853255 L FI 853255L FI 853255 A FI853255 A FI 853255A FI 853255 A FI853255 A FI 853255A FI 853255 L FI853255 L FI 853255L
Authority
FI
Finland
Prior art keywords
bensazepine
framstaellning
tetrahydro
chloro
methyl
Prior art date
Application number
FI853255A
Other languages
English (en)
Finnish (fi)
Other versions
FI853255A7 (fi
FI853255A0 (fi
Inventor
Stanley John Borowski
Thomas Anthony Post
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of FI853255A0 publication Critical patent/FI853255A0/fi
Publication of FI853255L publication Critical patent/FI853255L/fi
Publication of FI853255A7 publication Critical patent/FI853255A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
FI853255A 1984-09-05 1985-08-23 Menetelmä 6-kloori-N-metyyli-2,3,4,5 -tetrahydro-1H-3-bentsatsepiinin valmistamiseksi. FI853255A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/647,552 US4541954A (en) 1984-09-05 1984-09-05 Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Publications (3)

Publication Number Publication Date
FI853255A0 FI853255A0 (fi) 1985-08-23
FI853255L true FI853255L (fi) 1986-03-06
FI853255A7 FI853255A7 (fi) 1986-03-06

Family

ID=24597406

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853255A FI853255A7 (fi) 1984-09-05 1985-08-23 Menetelmä 6-kloori-N-metyyli-2,3,4,5 -tetrahydro-1H-3-bentsatsepiinin valmistamiseksi.

Country Status (19)

Country Link
US (1) US4541954A (enExample)
EP (1) EP0174118A3 (enExample)
JP (1) JPS6168469A (enExample)
KR (1) KR860002470A (enExample)
AU (1) AU581918B2 (enExample)
CA (1) CA1244017A (enExample)
DK (1) DK379985A (enExample)
EG (1) EG17149A (enExample)
ES (1) ES8609266A1 (enExample)
FI (1) FI853255A7 (enExample)
GR (1) GR852041B (enExample)
HU (1) HU194181B (enExample)
IL (1) IL76100A0 (enExample)
NO (1) NO853255L (enExample)
NZ (1) NZ213141A (enExample)
PH (1) PH20796A (enExample)
PT (1) PT81018B (enExample)
ZA (1) ZA856268B (enExample)
ZW (1) ZW13385A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
DE69218587T2 (de) * 1991-12-06 1997-08-14 Yuasa Battery Co Ltd Dünne batterie und monolitische dünne batterie
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
JP4782003B2 (ja) 2003-06-17 2011-09-28 アリーナ ファーマシューティカルズ， インコーポレイテッド ５ｈｔ２ｃレセプター関連疾患の処置に有用なベンズアゼピン誘導体
DK2332921T3 (en) * 2003-06-17 2016-05-09 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3benzazepine hydrochloride
RS50996B (sr) 2004-12-21 2010-10-31 Arena Pharmaceuticals Inc. Kristalni oblici (r)-8-hloro-1-metil-2,3,4,5-tetrahidro-1h-benzazepin hlorhidrat
KR101519441B1 (ko) 2004-12-23 2015-05-12 아레나 파마슈티칼스, 인크. 5ｈｔ２ｃ 수용체 조정물질 조성물 및 그의 사용 방법
CN101466684B (zh) 2006-04-03 2012-06-20 艾尼纳制药公司 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体
ES2522587T3 (es) * 2006-12-05 2014-11-17 Arena Pharmaceuticals, Inc. Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
WO2009111004A1 (en) * 2008-03-04 2009-09-11 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
MX2013002422A (es) 2010-09-01 2013-05-17 Arena Pharm Inc Sales de lorcaserina con acidos opticamente activos.
SG10201506865WA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
SG10201506874UA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
NZ630494A (en) 2010-09-01 2016-05-27 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
MY181736A (en) 2012-10-09 2021-01-05 Arena Pharm Inc Method of weight management

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
US4251660A (en) * 1978-08-10 1981-02-17 Smithkline Corporation Method for preparing tetrahydroisoquinolines
US4200754A (en) * 1979-02-02 1980-04-29 Smithkline Corporation Method for preparing 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline
IE53962B1 (en) * 1981-11-27 1989-04-26 Smithkline Beckman Corp 3-benzazepines as alpha-2 antagonists
DE3272044D1 (de) * 1981-11-27 1986-08-21 Smithkline Beckman Corp 3-benzazepines as alpha-2 antagonists
ZA827887B (en) * 1981-11-27 1983-11-30 Smithkline Beckman Corp Pharmaceutical compositions and method of producing alpha2 antagonism

Also Published As

Publication number Publication date
ZA856268B (en) 1986-07-30
EP0174118A2 (en) 1986-03-12
ZW13385A1 (en) 1985-11-20
AU581918B2 (en) 1989-03-09
PH20796A (en) 1987-04-14
ES546285A0 (es) 1986-09-01
KR860002470A (ko) 1986-04-26
GR852041B (enExample) 1985-12-19
EG17149A (en) 1989-06-30
DK379985A (da) 1986-03-06
CA1244017A (en) 1988-11-01
ES8609266A1 (es) 1986-09-01
PT81018B (en) 1987-06-24
HUT38617A (en) 1986-06-30
PT81018A (en) 1985-09-01
IL76100A0 (en) 1985-12-31
FI853255A7 (fi) 1986-03-06
EP0174118A3 (en) 1986-12-30
HU194181B (en) 1988-01-28
AU4648185A (en) 1986-03-13
NZ213141A (en) 1988-07-28
JPS6168469A (ja) 1986-04-08
DK379985D0 (da) 1985-08-21
NO853255L (no) 1986-03-06
FI853255A0 (fi) 1985-08-23
US4541954A (en) 1985-09-17

Similar Documents

Publication Publication Date Title
FI853193A0 (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
FI854625L (fi) Foerfarande foer framstaellning av pulverformigt, lineaert, basiskt polymerat.
FI853255A0 (fi) Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.
MX21592A (es) 1,3-oxazolidin-2-ona.
FI852765A0 (fi) Foerfarande foer framstaellning av saosom hjaertmedicin anvaendbara 1,6-naftyridin 2(1h)-oner.
FI852616A0 (fi) Foerfarande foer uppvaermning av tjockvaeggiga glasroer, jaemte anordning.
FI853837L (fi) Foerfarande foer framstaellning av isolerande, poroesa, formade byggelement.
FI853686A0 (fi) Foerfarande foer framstaellning av 2,4 -diklor-5-fluorbensoesyra.
FI852899L (fi) Foerfarande foer framstaellning av fenylsubstituerade 2,4,6,8-nonatetraensyror.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
FI841003L (fi) Foerfarande foer framstaellning av staellningar, speciellt stegar.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI853421A0 (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI853585L (fi) Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.
FI851520A0 (fi) Anordning foer sammanpressning av en blaosfolieslang.
FI855017L (fi) Foerfarande foer framstaellning av 26,26,26-trifluor-1 ,25-dihydroxikolekalciferol.
FI850604L (fi) Anordning foer styckevis tvaermaetning av laongstraeckta foeremaol, foeretraedesvis virkesstycken.
FI843270A0 (fi) Foerfarande foer industriellt utnyttjande av till en tjocklek av 0,2-0,3 mm skuret traefaner.
FI852372A0 (fi) Foerfarande foer framstaellning av substituerade 1,3-dioxanderivat.
FI902192A0 (fi) Foerfarande foer framstaellning av 1,3-dihydro-4-pyridinyl-2h-imidazol-2-oner.
FI850758A0 (fi) Foerfarande foer framstaellning av 3-metyl-7-fluor-5-nitrobenzotiofen.
FI841632A0 (fi) Foerfarande foer framstaellning av laett instaellbara, haollbara anod- och jaernfoerelseelektrodkomponenter foer katod katodiskt skydd.
FI850668A0 (fi) Anordning foer behandling av roekgaser, speciellt avgaser.
FI843391A0 (fi) Foerfarande foer framstaellning av osymmetriska 1,4-dihydropyridin dikarboxylsyraestrar.
FI842639A0 (fi) Acylderivat av 1,4,3,6-dianhydro- hexitol.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SMITHKLINE BECKMAN CORPORATION